迴天新材(300041.SZ):擬投6000萬元擴建鋰電池用聚氨酯膠及光伏密封膠生產線
格隆匯11月14日丨迴天新材(300041.SZ)公佈,為抓住新能源汽車行業機遇,匹配不斷增長的市場需求,公司擬以自籌資金約3900萬元投資新建聚氨酯自動化生產線,增加鋰電池用雙組分聚氨酯膠產能約1萬噸/年。
公司作為國內光伏膠粘劑龍頭企業,為保障未來供貨需求,進一步提高市場佔有率,鞏固行業優勢地位,擬以自籌資金約2100萬元投資新建雙螺桿全自動生產線,增加光伏單組分有機硅密封膠產能約3萬噸/年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.